In a significant discovery, a group of proteins long associated with cancer research has been shown to have an important link to Alzheimer’s disease. Among other implications, this advance could fast-track Alzheimer’s drug development, as there are already relevant therapies in active cancer trials. The protein family, protein kinase C, also known as ...
April 21, 2015
Featured Researcher: William Mobley, M.D., Ph.D. Distinguished Professor and Chair of the Department of Neurosciences at University of California, San Diego; Executive Director of UCSD’s Down Syndrome Center for Research and Treatment; Florence Riford Chair for Alzheimer’s Disease Research. Born in landlocked Nebraska, William Mobley discovered the wonders of research when he ...
July 28, 2014
Researchers at the University of California, San Diego School of Medicine have erased and reactivated memories in rats, profoundly altering the animals’ reaction to past events. The study, published in the June 1 advanced online issue of the journal Nature, is the first to show the ability to selectively remove a ...
May 30, 2014
On Saturday, January 4, Rudy Tanzi, Ph.D. appeared on CBS News’ This Morning to discuss the current state of research towards an Alzheimer’s cure. In the segment, Tanzi explains some of the reasons behind past drug failures and the ways in which the current generation of drugs in development will hopefully ...
January 6, 2014
Cure Alzheimer’s Fund Research Consortium member and funded researcher Steven L. Wagner, Ph.D., Principle Investigator, Department of Neurosciences; School of Medicine, and William C. Mobley, M.D., Ph.D., Distinguished Professor and Chair of the Department of Neurosciences, both from the University of California, San Diego, discuss how research into the cause ...
October 2, 2012
The CAF approach is working. UC San Diego neuroscientist Steve Wagner, a previous recipient of two substantial grants from Cure Alzheimer’s Fund (CAF), has been awarded a $1 million NIH “Blueprint” grant for the fast-track development of a promising Alzheimer’s drug therapy. “This is further validation of our venture model,” says CAF ...
October 4, 2011
Learn about the fascinating connection between cancer and Alzheimer’s from Dr. Alexandra Newton. Alexandra Newton, Ph.D., at University of California, San Diego has been studying the enzyme protein kinase C (PKC) for much of her career. While PKC has mainly been researched for its implications in cancer, we now suspect the enzyme plays ...
May 19, 2015
Please join us in congratulating Alan Arnette on his summit of Aconcogua, the second climb in his quest to reach the highest peak on each continent while raising awareness of Alzheimer’s disease and funds to support research for a cure. Alan was alo featured today in an impressive story in The ...
January 31, 2011
At ICAD 2010 in Hawaii Dr. Sam Gandy of Cure Alzheimer’s Research Consortium presented the results of a study showing a new class of biomarkers that can stick to protein structures in the body and emit colors reflecting the different shapes or forms of the proteins. They are called luminescent conjugated ...
July 15, 2010
Breakthrough research conducted by our very own Dr. Rudy Tanzi and his team at Massachusetts General Hospital has led to an important advancement in the understanding of the protein associated with Alzheimer’s disease. The prevailing theory has been that this protein — A-beta — has no function other than as a ...
March 9, 2010
